“The transition in healthcare” the title of the 2022 edition of Innovabiomed
The edition of Innovabiomed, the network place for biomedical innovation that on May 24 and 25 involved researchers, physicians, stakeholders, medical device manufacturers and companies operating in the health supply chain to connect different disciplines and skills useful for the development of the sector, closed with an excellent turnout.
Alberto Nicolini:”The city of Pico is always up to the task”
Raimondo Pische – a life set on work and basics extremely attentive to the toxicological aspect
SKY53 project presentation for the use of drones in healthcare
The transfer of medical-healthcare equipment by drones has long been destined to overcome the limitations inherent in traditional, often congested ground transportation, with the goal of reducing travel time, even over medium distances (about 100 km). This is a necessary breakthrough when thinking especially of urgent services such as the transport of life-saving organs or medicines, where time factor and speed of action are crucial.
Gabbrielli: “The fast transfer of medical and healthcare equipment by drones is set to overcome the limitations of traditional ground transportation, a breakthrough needed especially for urgent services such as transporting organs or life-saving medicines”
Drones that can save lives. This is how one can summarize what was previewed at Innovabiomed at the fair in Verona as part of the conference entitled “The Use of Drones in Healthcare – The Sky53 Project.“
The project, of absolute importance, involves private and public entities such as the Concessioni Autostradali Venete and the Istituto Superiore di Sanità, which have given rise to an extraordinarily innovative creation of digital healthcare. The conference, during which a practical demonstration of great visual impact also took place, featured as speakers: Ugo Dibennardo, CEO Concessioni Autostradali Venete – Venice; Sabato Fusco, technical director Concessioni Autostradali Venete; Francesco Gabbrielli, director of the National Center for Telemedicine and New Assistive Technologies at ISS; Roberto Calvi, technical director at Calvi Tecnologie, UAV Instructor Pilot, Expert in drone applications and for the development of Electromechanical and Medical Patents and Projects; and Eyal Regev, CEO Gadfin Transport Systems by Drones – Israel.
“The goal and ambition of this project,” explains Francesco Gabbrielli, “is to be able to use a part of our territory as if it were a huge test laboratory to be able to validate a system that uses drones to transport drugs and biological material, such as blood or even organs for transplantation. The greatest use of this system, however, will be to reach with appropriate drugs or relief materials to situations of particular distress of people or for emergency situations. This system allows us to reduce so much the time that passes from the moment a person is found, for example, unconscious and the moment when the treatment the person needs is applied. I emphasize the innovative type of public-private collaboration that we have developed, a collaboration that we so badly need in our digital health sector but that Italy, due to a series of regulatory constraints created over time to limit the possibility of illicit actions, is struggling to implement. This project may look like a technological innovation, but it is actually a process innovation that approaches on innovative technologies.”
“A necessary involvement,” explains Ugo Dibennardo, “since we manage a fundamental and strategic junction of the road system in the Northeast, in an area where health poles of excellence are located, but above all because it takes advantage of CAV’s technological infrastructure, which is already at an advanced stage of development for the use of drones for the purpose of monitoring works and traffic. As with mobility, health care is going through a momentous technological transition, and in this transition it is crucial to ensure a fast, efficient and safe transportation system so as not to compromise the effectiveness of the service.”
“Safety,” Sabato Fusco explains, “is one of the fundamental requirements of the project, both in terms of the flight control system and the drones themselves: the latter are equipped with a redundant command system, an anti-collision laser system, an emergency system in case of electromagnetic interference and parachutes.
At “Innovabiomed” the heart valve that will change healthcare
Regenerated organs, space medicine and barrier-free healthcare
3DiFiC of Perugia wins the Innovabiomed 2022 award
The Innovabiomed Prize in collaboration with Fondazione Cariverona, was awarded to 3DiFiC of Perugia and collected by Managing Director Alessandro Ricci. The event’s Scientific Committee gave the following reasons for the choice: “This reality responds to the demands for efficient and connected healthcare with all elements of the health supply chain. An example of convergence between health, science and industry with a strong social impact and high technological characterization.”
“DICOM2Holens,” this is the project presented, is a system that provides the surgeon with all the applications of medical 3D: from virtual surgical planning, to visualization with mixed reality using HoloLens viewers, to near-to-real 3D printing with materials that exactly replicate the mechanics of organs, to the realization of the specific implantable patient device. 3DiFiC Ltd. is an engineering company specializing in the knowledge and use of 3D printing and digital design.
The company is capable of working in any field of manufacturing, but the relationships it has built over time have led it to have a particularly in-depth knowledge of the field of custom medical device manufacturing.
Walter Ricciardi to Innovabiomed: “What italy will face will be a financial war, the appeal is to government, parliament and citizens, the health care system is at risk.”
“The third edition of Innovabiomed is going to be very important especially from the biotechnology point of view, extraordinary innovations will be presented, but they have to be made sustainable, and that is the real challenge. Innovations have to be funded and brought to patients, and this is the big question mark these days because the current financial planning does not provide adequate funding to introduce these tools and does not provide adequate funding to ensure staffing. There is a great and well-founded concern; it is imperative that we find a way for citizens to benefit from the innovations by ensuring staff who know how to use them. The NRP is a very important tool, at the moment huge efforts have been made to increase funding, but it is not enough, the current economic and financial programming for 2023/2025 provides less money than pre-pandemic funding and it is clear that with this programming the country has to make choices.” This was stated today by Walter Ricciardi, full professor of Hygiene and Public Health at the Faculty of Medicine of the Catholic University of the Sacred Heart in Rome, scientific advisor to the Minister of Health at the inaugural conference of Innovabiomed.
“It is fundamental to understand,” Ricciardi continued, “that investments must be made on health care even in conditions of great difficulty. What Italy will face will be a financial war, the appeal is to government, parliament and citizens, all realize that the national health system is at a crossroads and without important resources for personnel, the crossroads is taken in the wrong way. Citizens also need to be aware that the National Health System is not guaranteed, already right now we have huge problems, in the emergency room, in staffing, we are missing 35000 nurses, the problem is not tomorrow, the problem is today. Today we have to face an emergency and then we have to try to solve this emergency in such a way that in the near future this great public work that is the National Health System is guaranteed.”
Source: Ufficio Stampa Innovabiomed e Press Office Veronafiere